Dr Reddys Laboratories (RDY) Net Cash Flow (QoQ) (2009 - 2018)
Dr Reddys Laboratories (RDY) Net Cash Flow (QoQ) (2009 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -174.23% |
| Dec 31, 2017 | 215.80% |
| Dec 31, 2016 | -118.04% |
| Dec 31, 2015 | 65.38% |
| Sep 30, 2015 | -197.10% |
| Dec 31, 2013 | 158.81% |
| Sep 30, 2013 | -121.85% |
| Jun 30, 2013 | 507.69% |
| Mar 31, 2013 | -373.30% |
| Dec 31, 2012 | 115.65% |
| Sep 30, 2012 | -310.78% |
| Jun 30, 2012 | 118.89% |
| Mar 31, 2012 | -207.54% |
| Dec 31, 2011 | 33.84% |
| Mar 31, 2010 | 137.39% |
| Dec 31, 2009 | -41,275.00% |
| Sep 30, 2009 | 1,900.00% |